Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Head & Neck 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 22Squamous Cell Carcinoma of Head and Neck 16Colonic Neoplasms 11Rectal Neoplasms 8Head and Neck Neoplasms 7Neoplasm Metastasis 5Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Pancreatic Neoplasms 3Ovarian Neoplasms 2Esophageal Neoplasms 2Endometrial Neoplasms 2Chordoma 2Breast Neoplasms 2Unresectable Colorectal Cancer 1Tongue Neoplasms 1Thymoma 1Solid Tumor, Adult 1Solid Cancer 1Skin Neoplasms 1Rectal Diseases 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Oropharyngeal Neoplasms 1Noonan Syndrome 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Metastatic Colorectal Adenocarcinoma 1Lymphoid Interstitial Pneumonia 1Lung Neoplasms 1Laryngeal Neoplasms 1

Interventions

Nivolumab 4Ipilimumab 3Specimen Handling 2Magnetic Resonance Spectroscopy 2Cetuximab 2tazemetostat 1pembrolizumab 1atezolizumab 1X-Rays 1Tiragolumab 1Radiosurgery 1Proton Therapy 1Phantoms, Imaging 1Fluorodeoxyglucose F18 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Chordoma × Cetuximab × Clear all
NCT04670679 2026-03-25

FLAGSHP-1

Erasca, Inc.

Phase 1 Active not recruiting
90 enrolled
GastrointestinalHead & NeckSarcoma

Squamous Cell Carcinoma of Head and Neck, Chordoma, Neoplasm Metastasis, Neoplasms, Noonan Syndrome, Colorectal Neoplasms

NCT05041127 2026-02-19

Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
29 enrolled
Sarcoma

Chordoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡